Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial

Plutzky Jorge; Bogdański Paweł; Dagdelen Selçuk; Deanfield John; Emerson Scott; Hovingh G.; Kahn Steven; Larsen Signe; Gustavs Latkovskis; Lehrke Michael; Hardt-Lindberg Søren

doi:10.1016/j.atherosclerosis.2024.118518

Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial

Plutzky Jorge
, Bogdański Paweł
, Dagdelen Selçuk
, Deanfield John
, Emerson Scott
, Hovingh G.
, Kahn Steven
, Larsen Signe
, Gustavs Latkovskis
, Lehrke Michael
, Hardt-Lindberg Søren

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Atherosclerosis
Volume	395
DOIs	https://doi.org/10.1016/j.atherosclerosis.2024.118518
Publication status	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

OECD Field of Science

3. Medical and Health Sciences

Access to Document

10.1016/j.atherosclerosis.2024.118518

Cite this

@article{dc46e7630a2d40188d64fe44a6fac159,

title = "Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial",

author = "Plutzky Jorge and Bogda{\'n}ski Pawe{\l} and Dagdelen Sel{\c c}uk and Deanfield John and Emerson Scott and Hovingh G. and Kahn Steven and Larsen Signe and Gustavs Latkovskis and Lehrke Michael and Hardt-Lindberg S{\o}ren",

year = "2024",

doi = "10.1016/j.atherosclerosis.2024.118518",

language = "English",

volume = "395",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial

AU - Jorge, Plutzky

AU - Paweł, Bogdański

AU - Selçuk, Dagdelen

AU - John, Deanfield

AU - Scott, Emerson

AU - G., Hovingh

AU - Steven, Kahn

AU - Signe, Larsen

AU - Latkovskis, Gustavs

AU - Michael, Lehrke

AU - Søren, Hardt-Lindberg

PY - 2024

Y1 - 2024

UR - https://www.sciencedirect.com/science/article/pii/S0021915024010852

U2 - 10.1016/j.atherosclerosis.2024.118518

DO - 10.1016/j.atherosclerosis.2024.118518

M3 - Meeting abstract

SN - 0021-9150

VL - 395

JO - Atherosclerosis

JF - Atherosclerosis

ER -

Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial

UN SDGs

OECD Field of Science

Access to Document

Other files and links

Cite this